TRPC1 and Insulin resistance: These findings suggest that endothelial TRPC1 deficiency drives adipocyte hypertrophy in eWAT, leads to aberrant lipid deposition in serum, disrupts glucose and lipid metabolic homeostasis, and ultimately contributes to systemic insulin resistance.